Efficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly diagnosed chronic myeloid leukemia in chronic phase

Comprehensive therapeutic outcomes of frontline imatinib mesylate in newly diagnosed chronic phase chronic myeloid leukemia patients in Korea: feasibility assessment of current ELN recommendation

(2012) Dongho Kim et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)

(2012) B Hanfstein et al.   LEUKEMIA

A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer

(2012) King Pan Ng et al.   NATURE MEDICINE

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

(2011) H. M. Kantarjian et al.   BLOOD

Long-term pattern of pleural effusion from chronic myeloid leukemia patients in second-line dasatinib therapy

(2011) Dongho Kim et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors

(2011) David Marin et al.   JOURNAL OF CLINICAL ONCOLOGY

Characteristics of BCR–ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients

(2010) YaZhen Qin et al.   ANNALS OF HEMATOLOGY

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

(2010) Hagop Kantarjian et al.   NEW ENGLAND JOURNAL OF MEDICINE

Analysis of Bcr-Abl kinase domain mutations in Korean chronic myeloid leukaemia patients: poor clinical outcome of P-loop and T315I mutation is disease phase dependent

(2009) Soo-Hyun Kim et al.   HEMATOLOGICAL ONCOLOGY

Clinical profile of dasatinib in Asian and non-Asian patients with chronic myeloid leukemia

(2009) Dong-Wook Kim et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia

(2009) Hisashi Sakamaki et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Chronic myeloid leukemia in Asia

(2008) Wing Y. Au et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY